SHEIN, the fast-growing fashion retailer, is reportedly in talks with the London Stock Exchange for possible listing. The company is said to be holding discussions with the LSE last week as it eyes a potential listing in the United Kingdom.
According to Sky News, Donald Tang, executive chairman of SHEIN, met up with executives from the LSE and stockholders in the U.K. economy sector during his business trip to London last week. Insiders said that the discussions between the officials were mostly about the possibility of listing the fashion company in Europe.
Raising of Capital for the Listing
The sources added that SHEIN continues exploring different options and ways to raise capital by selling public shares. In addition, it was learned that even if the company’s plans for New York floatation in 2024 are in progress, the recent talks for the London Stock Exchange listing continued.
The fast-fashion retailer is said to be confident during the talks and looking forward to a possible smash-hit public listing in the U.K. At the same time, SHEIN is also filing documents in New York for an initial public offering.
Confidential Filing with the SEC
Meanwhile, based on the reports, SHEIN’s filing to go public with the U.S. Securities and Exchange Commission (SEC) was originally a confidential matter. However, a number of media publications got wind of its plans, so the listing in New York was divulged last month.
Reuters reported that the company hired major firms such as Morgan Stanley, Goldman Sachs, and JPMorgan Chase to be its lead underwriters of the initial public offering (IPO) in the U.S. It was revealed that SHEIN may also launch a new share sale next year.
Photo by: Tokumeigakarinoaoshima/Wikimedia Commons(CC BY-SA 4.0)


Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
AFT Leaves X Over AI-Generated Images of Minors
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 



